Page last updated: 2024-11-02

phenoxybenzamine and Scleroderma, Systemic

phenoxybenzamine has been researched along with Scleroderma, Systemic in 2 studies

Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research Excerpts

ExcerptRelevanceReference
"Mixed connective tissue disease is characterized by overlapping features of classic connective tissue diseases and the presence of antibodies to ribonucleoprotein."2.36Mixed connective tissue disease: an overview. ( Callen, JP, 1982)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blunt, RJ1
Porter, JM1
Callen, JP1

Reviews

2 reviews available for phenoxybenzamine and Scleroderma, Systemic

ArticleYear
Raynaud syndrome.
    Seminars in arthritis and rheumatism, 1981, Volume: 10, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Angiography; Antibodies, Antinuclear; Arterial Occlusive Disease

1981
Mixed connective tissue disease: an overview.
    Southern medical journal, 1982, Volume: 75, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Child; Cold Temperature; D

1982